CD274 and neoplasm: Buisseret proposed that PD-L1 expression correlates with a higher density of TILs, including CD19+ B cells, suggesting that B cell infiltration in tumor tissues may be driven by immunotherapy targeting the PD-1/PD-L1 axis (212).